Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Personalized Cell Therapies Market: By Cell Type, By Application, and Geography
Personalized Cell Therapies Market: By Cell Type, By Application, and Geography
Personalized Cell Therapies Market size was valued at US$ 12,252.24 million in 2023 and is poised to grow at a CAGR of 23.6% from 2024-2030. The market for customized cell therapy is experiencing radical shifts due to expanding clinical applications, improved production processes, and advancements in gene editing technologies such as CRISPR. More focus is being placed on the development of autologous therapies, which use a patient's own cells to increase the specificity and efficacy of treatment.
Increased regulatory support and a substantial investment in research and development are also accelerating the commercialization of innovative cell-based therapies. Research & Development is evolving, various cell types developed into treatments as novel cell therapies due to its potential applications. Bone marrow transplant or hematopoietic stem cell transplant widely used cell therapy due to the treatment of blood cancer. Increased prevalence of cancer, a rise in research and adoption of advanced technologies are expected attract the demand for the market.
Study Period
2024-2030Base Year
2023CAGR
23.6%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The rise in prevalence of chronic disorders and unmet needs in current treatment methods are expected to catapult the personalized cell therapies market. Increasing prevalence of various disorders such as diabetes, cancer, autoimmune disorders, neurovascular disorders is expected to create demand for personalized cell therapies market over the forecast period. Moreover, potential applications of cell therapies include treating autoimmune disease, cancers, infectious disease, urinary problems, spinal cord injuries, rebuilding damaged cartilage in joints, improving a weakened immune system, neurological disorders are expected to create lucrative opportunities for the market.
U.S. market is expected to grow at the significant rate due to state-of-art healthcare infrastructure, increase in R&D, public and private funds for cellular therapies are expected to propel the market. Asia Pacific market is expanding at lucrative growth rate owing to increase in healthcare expenditure, raising awareness about novel cellular therapies in China and India. Rise in the medical tourism due to cost effectiveness is expected to trigger the demand for market over the forecast period. Stringent regulations, limited awareness in low-income countries are major restraints of the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 12,252.24 million |
|
Market CAGR |
23.6% |
|
By Cell Type |
|
|
By Application |
|
|
By Region |
|
Download Free Sample Report
The global personalized cell therapies market size was valued at US$ 12,252.24 million in 2023 and is projected to grow at a CAGR of 23.6% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
PCT Cell Therapy Services, LLC (U.S) S. Stem Cell, Inc. (U.S) Bellicum Pharmaceuticals, Inc. (U.S) Saneron CCEL Therapeutics, Inc. (U.S) StemGenex (U.S)
| 1.Executive Summary |
| 2.Global Personalized Cell Therapies Market Introduction |
| 2.1.Global Personalized Cell Therapies Market - Taxonomy |
| 2.2.Global Personalized Cell Therapies Market - Definitions |
| 2.2.1.Cell Type |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Personalized Cell Therapies Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Personalized Cell Therapies Market Analysis, 2019-2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Personalized Cell Therapies Market By Cell Type, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Hematopoietic Stem Cell |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Skeletal Muscle Stem Cell |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Mesenchymal Stem Cells |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Lymphocytes |
| 5.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Others |
| 5.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 6.Global Personalized Cell Therapies Market By Application, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Cardiovascular Disorders |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Diabetes |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Neurological Disorders |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Cancer |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Personalized Cell Therapies Market By Region, 2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Cell Type Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Hematopoietic Stem Cell |
| 8.1.2.Skeletal Muscle Stem Cell |
| 8.1.3.Mesenchymal Stem Cells |
| 8.1.4.Lymphocytes |
| 8.1.5.Others |
| 8.2. Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Cardiovascular Disorders |
| 8.2.2.Diabetes |
| 8.2.3.Neurological Disorders |
| 8.2.4.Cancer |
| 8.2.5.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Hematopoietic Stem Cell |
| 9.1.2.Skeletal Muscle Stem Cell |
| 9.1.3.Mesenchymal Stem Cells |
| 9.1.4.Lymphocytes |
| 9.1.5.Others |
| 9.2. Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cardiovascular Disorders |
| 9.2.2.Diabetes |
| 9.2.3.Neurological Disorders |
| 9.2.4.Cancer |
| 9.2.5.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10.Asia Pacific (APAC) Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Hematopoietic Stem Cell |
| 10.1.2.Skeletal Muscle Stem Cell |
| 10.1.3.Mesenchymal Stem Cells |
| 10.1.4.Lymphocytes |
| 10.1.5.Others |
| 10.2. Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cardiovascular Disorders |
| 10.2.2.Diabetes |
| 10.2.3.Neurological Disorders |
| 10.2.4.Cancer |
| 10.2.5.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Hematopoietic Stem Cell |
| 11.1.2.Skeletal Muscle Stem Cell |
| 11.1.3.Mesenchymal Stem Cells |
| 11.1.4.Lymphocytes |
| 11.1.5.Others |
| 11.2. Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cardiovascular Disorders |
| 11.2.2.Diabetes |
| 11.2.3.Neurological Disorders |
| 11.2.4.Cancer |
| 11.2.5.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Personalized Cell Therapies Market ,2019-2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Hematopoietic Stem Cell |
| 12.1.2.Skeletal Muscle Stem Cell |
| 12.1.3.Mesenchymal Stem Cells |
| 12.1.4.Lymphocytes |
| 12.1.5.Others |
| 12.2. Application Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cardiovascular Disorders |
| 12.2.2.Diabetes |
| 12.2.3.Neurological Disorders |
| 12.2.4.Cancer |
| 12.2.5.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.PCT Cell Therapy Services, LLC (U.S) |
| 13.2.2.S. Stem Cell, Inc. (U.S) |
| 13.2.3.Bellicum Pharmaceuticals, Inc. (U.S) |
| 13.2.4.Saneron CCEL Therapeutics, Inc. (U.S) |
| 13.2.5.StemGenex (U.S) |
| 13.2.6.Vericel Corporation.(U.S) |
| 13.2.7.Cytori Therapeutics Inc.(U.S.) |
| 13.2.8.MolMed S.p.A. (Italy) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.